ROSUVASTATIN CALCIUM
| Brand name | EZALLOR SPRINKLE |
|---|---|
| Active ingredient | ROSUVASTATIN CALCIUM |
| Strength | EQ 40MG BASE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2018 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 10413543 | February 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.